Ting‐Chao Chou

36.1k citations

350 papers · 29.3k indexed · 5 hit papers · h-index 60

Molecular Biology top 0.1%
Oncology top 0.1%
Organic Chemistry top 0.2%
Infectious Diseases top 0.2%
Virology top 0.1%

Co-authors: Paul Talalay Samuel J. Danishefsky Darryl Rideout Martin Hirsch George J. Bosl Robert J. Motzer Yanli Tong S Shu
Topics: HIV/AIDS drug development and treatment (54 papers)Cancer Treatment and Pharmacology (49 papers)Cancer therapeutics and mechanisms (45 papers)
Cited by: Virology Oncology Toxicology
Journals: Science Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Taiwan Japan

In The Last Decade

Ting‐Chao Chou

343 papers receiving 28.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1984 6.1k citations Ting‐Chao Chou et al. profile →
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

2010 4.5k citations Ting‐Chao Chou Cancer Research profile →
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

2006 4.2k citations Ting‐Chao Chou profile →
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

2000 701 citations Lisa A. Cavacini, Hermann Katinger et al. profile →
Analysis of combined drug effects: a new look at a very old problem

1983 526 citations Ting‐Chao Chou et al. profile →

Peers

Countries citing papers authored by Ting‐Chao Chou

Since Specialization

Citations

This map shows the geographic impact of Ting‐Chao Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Chao Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Chao Chou more than expected).

Fields of papers citing papers by Ting‐Chao Chou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Chao Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Chao Chou. The network helps show where Ting‐Chao Chou may publish in the future.

Co-authorship network of co-authors of Ting‐Chao Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Chao Chou. A scholar is included among the top collaborators of Ting‐Chao Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Chao Chou. Ting‐Chao Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing Patient Outcomes in Head and Neck Cancer Radiotherapy: Integration of Electronic Patient-Reported Outcomes and Artificial Intelligence-Driven Oncology Care Using Large Language Models 2025 ·Cancers ·(unknown),(unknown),Tianxiang Lin,Ting‐Chao Chou,(unknown)	0
2	Confined Atomically Mo‐Regulating Co³⁺ Sites Enhanced Electrocatalytic Seawater Oxidation 2025 ·Advanced Functional Materials ·Hongwei Ma,(unknown),(unknown),Yuanyuan Chang,Ting‐Chao Chou,Daying Guo,Guoyong Fang,(unknown),Xian Chen,Shun Wang	6
3	Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer 2021 ·Cancers ·(unknown),(unknown),(unknown),Ting‐Chao Chou,Richard J. Wong,Shu‐Fu Lin	6
4	Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method. 2016 ·Europe PMC (PubMed Central) ·Ning Zhang,Jianing Fu,Ting‐Chao Chou	158
5	Synthesis and antitumor evaluation of novel Benzo[d]pyrrolo[2,1-b]thiazole derivatives 2012 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Chi‐Wei Chen,Pei‐Chih Lee,Rajesh Kakadiya,Huajin Dong,(unknown),(unknown),Ting‐Chao Chou,Te‐Chang Lee,Anamik Shah,Tsann-Long Su	34
6	Iso-oxazole-Fludelone (KOS-1803) as a potent and efficacious microtubule-stablization epothilone against xenograft tumors. 2008 ·Cancer Research ·Ting‐Chao Chou,Xiu-Guo Zhang,Huajin Dong,Ziyang Zhong,Feng Li,Yong Li,(unknown),(unknown),Robert A. Johnson,Samuel J. Danishefsky	1
7	The mass-action law-based new computer software, CompuSyn, for automated simulation of synergism and antagonism in drug combination studies 2007 ·Cancer Research ·Ting‐Chao Chou,(unknown)	11
8	Design, experimentation and computerized automated data analysis of synergistic drug combinations against xenograft tumors by Taxotere and T900607 2005 ·Cancer Research ·Ting‐Chao Chou,Huajin Dong,Pieter B.M.W.M. Timmermans	7
9	Primary African HIV Clade A and D Isolates: Effective Cross-Clade Neutralization with a Quadruple Combination of Human Monoclonal Antibodies Raised against Clade B 2003 ·AIDS Research and Human Retroviruses ·(unknown),Flavia Ferrantelli,Tao Wang,(unknown),Hermann Katinger,Gabriela Stiegler,Lisa A. Cavacini,Ting‐Chao Chou,Ruth M. Ruprecht	20
10	Synthesis and biological activity of AHMA-EDTA conjugates 2002 ·Medicinal Chemistry Research ·(unknown),Ting‐Chao Chou,Chun‐Yuan Ting,(unknown),Jaulang Hwang,(unknown)	1
11	Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505 2002 ·Annals of Oncology ·Kuniaki Itoh,T. Ohtsu,Haruhiko Fukuda,Yusuke Sasaki,Michinori Ogura,Y Morishima,Ting‐Chao Chou,Kohsuke Aikawa,Naokuni Uike,(unknown),Tatsuharu Ohno,Shu‐ichi Ikeda,(unknown),Masafumi Taniwaki,(unknown),Miyuki Niimi,T Hotta,M Shimoyama,Kensei Tobinai	44
12	The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice. 1995 ·PubMed ·Yue Tu,S M Stepkowski,Ting‐Chao Chou,(unknown)	42
13	Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice. 1994 ·PubMed ·S M Stepkowski,(unknown),Ting‐Chao Chou,B D Kahan	3
14	Synergistic Neutralization of HIV-1 by Human Monoclonal Antibodies Against the V3 Loop and the CD4-Binding Site of gp120 1992 ·AIDS Research and Human Retroviruses ·S A Tilley,(unknown),(unknown),Ting‐Chao Chou,(unknown)	85
15	Three-Drug Synergistic Inhibition of HIV-1 Replication In Vitro by 3′-Fluoro-3′-Deoxythymidine, Recombinant Soluble CD4, and Recombinant Interferon-Alpha 1992 ·AIDS Research and Human Retroviruses ·(unknown),(unknown),P. A. Baron,Jonathan Gold,Bruce Polsky,Ting‐Chao Chou,Donald Armstrong	10
16	Differential Alteration of the Anti-HIV-1 Effect of Phosphorothioate Oligonucleotide S-dC28 by AZT, Interferon-Alpha, and Dextran Sulfate 1991 ·AIDS Research and Human Retroviruses ·Ting‐Chao Chou,(unknown),Cy A. Stein	7
17	Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity. 1988 ·The Journal of Immunology ·Ting‐Chao Chou,(unknown),S Shu	74
18	Conservation of laboratory animals by improved experimental design, generalized equations and computer analysis 1984 ·Federation Proceedings ·Ting‐Chao Chou,Joanne F. Chou,(unknown)	2
19	Kinetic and biochemical modulation of pyrimidine antimetabolites in therapy of acute leukemia 1981 ·Proceedings of the American Association for Cancer Research ·Martin S. Blumenreich,M. Andreeff,Ting‐Chao Chou	1
20	Comparison of the mass action law with the power law the probit law and the logit law in dose effect analyses 1977 ·Ting‐Chao Chou	4

About Ting‐Chao Chou

Ting‐Chao Chou is a scholar working on Virology, Toxicology and Organic Chemistry, having authored 350 papers that have together received 29.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (54 papers), Cancer Treatment and Pharmacology (49 papers) and Cancer therapeutics and mechanisms (45 papers). The work is most often cited by research in Virology (2.8k citations), Oncology (8.1k citations) and Toxicology (872 citations). Ting‐Chao Chou has collaborated with scholars based in United States, Taiwan and Japan. Frequent co-authors include Paul Talalay, Samuel J. Danishefsky, Darryl Rideout, Martin Hirsch, George J. Bosl, Robert J. Motzer, Yanli Tong, S Shu, Aaron Balog and Huajin Dong. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact